2022 Agenda

Tuesday, November 8

 Subject to change

Time

Event

7:00 am

Registration

8:10 am –  Villard Ballroom

Welcome Remarks

  • Sara Jane Demy, Founder & CEO, Demy-Colton

8:20 am – Villard Ballroom

“Big Think” Plenary Session 

Health at a Crossroads: What is the Path Forward?

Moderator:

  • Jeremy Abbate, Vice President & Publisher, Scientific American

Panelists:

  • Kush M. Parmar, MD, PhD, Managing Partner, 5AM Ventures

9:30 am – Holmes I

Next-Generation Cancer Therapeutics

Moderator: 

  • Jay Campbell, Managing Director, Clinical Accelerator & Venture Fund, Cancer Research

Institute 

Panelists:

  • Jennifer Buell, PhD, CEO, MiNK Therapeutics
  • William Ho, Founder, President & CEO, IN8bio
  • Steven O’Day, MD, CMO, Agenus 
  • Lihua Zheng, PhD, Chief Business Officer & Co-Founder, AnHeart Therapeutics

9:30 am – Holmes II

Think Different: Commercialization as Innovation

Moderator:

  • Beth Rogozinski, CEO, Oncoustics

Panelists:

  • Melissa Bianchi, Partner, Hogan Lovells
  • Everett Crosland, Chief Commercial Officer, Cognito Therapeutics 
  • Andy Molnar, CEO, Digital Therapeutics Alliance
  • Komathi Stem, COO, Glooko

10:30 am – Holmes I

Neurotech: Non-Invasive Neuromodulation and Brain-Computer Interfaces

Moderator:

  • Hilary Brueck, Health Correspondent, Insider

Panelists:

  • David Suendermann-Oeft, PhD, CEO, Modality AI
  • Brent Vaughan, CEO, Cognito Therapeutics
  • Peter Yoo, PhD, Senior Director, Neuroscience, Synchron

10:30 am – Holmes II

Gene Editing Therapies

Moderator:

  • Querida Anderson, Managing Editor, Fierce Pharma

Panelists:

  • Parastoo Khoshakhlagh, PhD, CEO & Co-Founder, GC Therapeutics
  • Daniel Oliver, CEO & Co-Founder, Rejuvenate Bio

11:30 am – Holmes I

Leveraging AI and ML to Advance Discovery and Accelerate Drug Development

Panelists:

  • Christine Becker, Director, Preclinical Biology, Ochre Bio
  • Rabia Khan, CEO, Ladder Therapeutics
  • Han Lim, PhD, CSO, DeepCure

12:30 pm – Villard Ballroom

Food For Thought

Fireside Chat: Deeper into the Data for Transformative Health

  • Leroy Hood, MD, PhD, Chief Strategy Officer, Co-Founder and Professor, Institute for Systems Biology and CEO/Founder, Phenome Health
  • Scott Penberthy, Director, Applied AI, Office of the CTO, Google

2:00 pm – Holmes I

TechBio: Investment Fad or Here to Stay? 

Moderator: 

  • Kimberly Ha, Founder & CEO, KKH Advisors

Panelists:

  • Amee Kapadia, Investor, Cantos Ventures
  • Chas Pulido, Founder & General Partner, Alix Ventures 
  • Dylan Reid, Partner, Zetta Venture Partners
  • Shaq Vayda, Senior Associate, Lux Capital

3:00 pm – Holmes I

Impact of Wearable Sensors & Affective Computing 

Moderator:

  • Walter Greenleaf, PhD, Distinguished Visiting Scholar, Stanford University’s MediaX Program

Panelists:

  • Nanea Reeves, CEO & Co-Founder, TRIPP, Inc.

3:00 pm – Holmes II

Women’s Health: Getting the Long Overdue Research Attention, Investment, & Innovation

Moderator:

  • Pooja Majmudar, PhD, Director, Startup Banking, Silicon Valley Bank

Panelists:

  • Jennifer Garrison, PhD, Assistant Professor, Research on Aging, Buck Institute
  • Chihiro Hosoya, Head of Venture Management & Business Development, Astellas Rx+Business Accelerator
  • Anna Nakayasu, MD, Principal, Sozo Ventures
  • Mylene Yao, MD, Co-Founder & CEO, Univfy

4:00 pm – Holmes I

Fostering Innovation and Collaboration Across a Hybrid/Remote Workforce 

Moderator:

  • Susanna Harris, PhD, Head, Communications, VIBE

Panelists:

  • David Fortier, Managing Partner, Global Life Sciences Practice Leader, ZRG

5:00 pm – Villard Ballroom

A “Big Think” Plenary

Funding Innovation: What is the New Normal?

Moderator:

  • Tim Opler, PhD, Partner & Co-Founder, Torreya

Panelists:

  • Rachelle Jacques, President & CEO, Akari Therapeutics
  • Peter Rehnquist, Director, Corporate Development, XOMA
  • Allan Shaw, CFO, Portage Biotech, Inc.

Be a part of BioFuture

© 2022 BioFutureTM. All Rights Reserved

Produced by